par Bartlett, John M S;Poole, Christopher;Shepherd, Lois;Cardoso, Fatima 
;Jensen, Maj Britt;Caldas, Carlos;Twelves, Chris;Rea, Daniel William;Ejlertsen, Bent;Leo, Angelo;Pritchard, Kathleen;McConkey, Christopher C.C.;Munro, Alison;Desmedt, Christine ;Dunn, Janet J.A.;Larsimont, Denis ;O'Malley, Frances Philomena;Cameron, David D.A.;Earl, Helena
Référence Journal of clinical oncology, 33, 15, page (1680-1687)
Publication Publié, 2015-05
;Jensen, Maj Britt;Caldas, Carlos;Twelves, Chris;Rea, Daniel William;Ejlertsen, Bent;Leo, Angelo;Pritchard, Kathleen;McConkey, Christopher C.C.;Munro, Alison;Desmedt, Christine ;Dunn, Janet J.A.;Larsimont, Denis ;O'Malley, Frances Philomena;Cameron, David D.A.;Earl, HelenaRéférence Journal of clinical oncology, 33, 15, page (1680-1687)
Publication Publié, 2015-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bartlett, John M S; Poole, Christopher; Shepherd, Lois; Cardoso, Fatima; Jensen, Maj Britt; Caldas, Carlos; Twelves, Chris; Rea, Daniel William; Ejlertsen, Bent; Leo, Angelo; Pritchard, Kathleen; McConkey, Christopher C.C.; Munro, Alison; Desmedt, Christine; Dunn, Janet J.A.; Larsimont, Denis; O'Malley, Frances Philomena; Cameron, David D.A.; Earl, Helena |
| Informations sur la publication: | Journal of clinical oncology, 33, 15, page (1680-1687) |
| Statut de publication: | Publié, 2015-05 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Anthracyclines -- therapeutic use |
| Antigens, Neoplasm -- genetics | |
| Antineoplastic Agents -- therapeutic use | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Biomarkers, Tumor | |
| Centromere -- chemistry | |
| Chromosomes, Human, Pair 17 -- genetics | |
| Clinical Trials, Phase III as Topic | |
| Cyclophosphamide -- therapeutic use | |
| DNA Topoisomerases, Type II -- genetics | |
| DNA-Binding Proteins -- genetics | |
| Disease-Free Survival | |
| Fluorescent Dyes -- chemistry | |
| Fluorouracil -- therapeutic use | |
| Genetic Markers | |
| Humans | |
| In Situ Hybridization, Fluorescence | |
| Methotrexate -- therapeutic use | |
| Neoplasm Recurrence, Local | |
| Neoplasms -- drug therapy -- genetics | |
| Prognosis | |
| Proportional Hazards Models | |
| Treatment Outcome | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2013.54.7869 | |
| info:pii/JCO.2013.54.7869 | |
| info:scp/84933575890 | |
| info:pmid/25897160 |
